Your browser doesn't support javascript.
loading
Flow Cytometry Method Validation Protocols.
Selliah, Nithianandan; Nash, Veronica; Eck, Steven; Green, Cherie; Oldaker, Teri; Stewart, Jennifer; Vitaliti, Alessandra; Litwin, Virginia.
Affiliation
  • Selliah N; Cerba Research, Lake Success, New York.
  • Nash V; Cerba Research, Lake Success, New York.
  • Eck S; AstraZeneca, Gaithersburg, Maryland.
  • Green C; Ozette Technologies, Seattle, Washington.
  • Oldaker T; Independent Consultant, San Clemente, California.
  • Stewart J; Flow Contract Site Laboratory, LLC, Bothell, Washington.
  • Vitaliti A; Novartis Institute for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
  • Litwin V; Eurofins BioPharma Services, Montréal, Québec, Canada.
Curr Protoc ; 3(8): e868, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37606503
ABSTRACT
Analytical method validation provides a means to ensure that data are credible and reproducible. This article will provide a brief introduction to analytical method validation as applied to cellular analysis by flow cytometry, along with practical procedures for four different types of validation. The first, Basic Protocol 1 (the limited validation protocol), is recommended for research and non-regulated laboratories. Next, Basic Protocol 2) presents a reasonable, fit-for-purpose validation approach appropriate for biopharma and research settings. Basic Protocol 3 addresses the type of validation performed in clinical laboratories for moderate-risk tests developed in house. Finally, Basic Protocol 4 describes the process that should be applied whenever a method is being transferred from one facility to another. All four validation plans follow the fit-for-purpose validation approach, in which the validation parameters are selected based on the intended use of the assay. These validation protocols represent the minimal requirement and may not be applicable for every intended use such as high-risk clinical assays or data to be used as a primary endpoint in a clinical trial. The recommendations presented here are consistent with the white papers published by the American Association of Pharmaceutical Scientists and the International Clinical Cytometry Society, as well as with Clinical Laboratory Standards Institute Guideline H62 Validation of Assays Performed by Flow Cytometry (CLSI, 2021). © 2023 Wiley Periodicals LLC. Basic Protocol 1 Limited validation Basic Protocol 2 Fit-for-purpose validation for biopharma and research settings Basic Protocol 3 Validation for moderate clinical risk laboratory developed tests Basic Protocol 4 Transfer validation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Clinical Laboratory Services Type of study: Guideline Language: En Journal: Curr Protoc Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Clinical Laboratory Services Type of study: Guideline Language: En Journal: Curr Protoc Year: 2023 Type: Article